Patients with liver cirrhosis and hilar CC shouldn't be precluded from surgical resection. The resection must be at high volume centers with expertise. The incidence of early postoperative liver cell failure was significantly higher. a r t i c l e i n f o 
Introduction
Extrahepatic cholangiocarcinoma (CC) is infrequently reported with a background of liver cirrhosis [1] . However, the incidence of intrahepatic CC associated with hepatitis C virus (HCV) induced cirrhosis is estimated to be 0.3% per year [2] . The relation between HCV induced cirrhosis and CC is still unclear and there are conflicting results in the literature which mandates further studies [3] . Although multiple studies asserted the increased risk of intrahepatic CC in patients with HCV liver cirrhosis, there is no reported association between HCV cirrhosis and extrahepatic CC [4] .
Established risk factors for extrahepatic CC include primary sclerosing cholangitis, parasitic infection, choledocholithiasis, and toxins [5] . The presence of schistosomiasis, chronic typhoid infection, cholecystolithiasis together with environmental pollution contribute to the high incidence of cholangiocarcinoma in Egypt [6] . Egypt is also known for the highest worldwide prevalence of HCV infection and its complications, especially liver cirrhosis [7] . This made the association between extrahepatic CC and HCV induced cirrhosis a relatively common finding in our center.
Traditionally, cirrhosis has been considered as an absolute contraindication to major abdominal operation. The hospital mortality rates have been reported to be 17.5%e38% in cirrhotic patients undergoing any abdominal operation [1e6] . To our knowledge, this is the first study that exclusively examines the impact of cirrhosis on surgical management of extrahepatic CC in one of the hot spots of HCV induced cirrhosis in the world [6] .
As surgical resection is the only hope of cure for patients with CC [8] , this study is designed to assess the impact of cirrhosis on the outcome of surgical management for CC. It also helps to investigate how the presence of cirrhosis can change the surgical decision.
Patients and methods
This is a retrospective study on 243 patients who underwent surgical resection for pathologically proven hilar CC between January 1995 and December 2010 in the Gastrointestinal Surgical Center, Mansoura University, Egypt. Patient data were collected from a prospectively maintained database on an internal webbased registry system supplemented by paper records. Patients were then divided into two groups according to the liver status: cirrhotic and non cirrhotic patients. Cirrhosis was diagnosed by liver biopsy. The extent of liver cirrhosis was estimated by the modified ChildeTurcotteePugh (CTP) classification [9] .
Preoperative assessment
Preoperative evaluation of tumor extent was done by triphasic abdominal computerized tomography (CT), and/or magnetic resonance cholangiopancreatography (MRCP). Preoperative portal vein embolization was not done in any case. Routine esophagogastroscopy was done for all cirrhotic patients for assessment and management of esophageal and gastric varices. Preoperative biliary drainage was done in patients with clinical features of cholangitis. Preoperative biliary drainage was achieved by ultrasound guided (US) percutaneous transhepatic drainage (PTD) or by endoscopic retrograde cholangiography (ERC) and stenting.
In this study, candidates for surgical management were patients with resectable extrahepatic CC with CTP classes A and B (patient's score less than 8). Patients were excluded from surgery when they were CTP classes B (patient's score > 8), CTP class C, patients with risk of bleeding esophageal or gastric varices and patients with thrombosed portal vein.
Surgical procedure
Laparotomy was done through a bilateral subcostal incision with an upward midline extension. Intraoperative US was done to assess tumor extent, its relation to major vascular structures and to map extent of liver resection. Liver resection was carried out using a harmonic scalpel with or without intermittent inflow clamping (Pringle's maneuver). A minor liver resection was defined as resection of three or fewer segments while major liver resection was resection of four segments or more according to the Couinaud nomenclature. All patients underwent concomitant extrahepatic biliary resection and lymphadenectomy of loco-regional LNs. Lymphadenectomy was carried out starting from the celeic trunk upward toward the hilum to include all regional lymph nodes and lymphatics with enbloc resection of the primary tumor. The regional lymph nodes included the cystic duct, pericholedochal, hilar, periportal, periduodenal, peripancreatic and celiac nodes.
Postoperative management
After surgery, all patients were admitted to the Intensive Care Unit in the early post operative period and received standard post operative care by the same surgical team thereafter.
Liver functions were measured on the first postoperative day, postoperative day (POD) 3 and POD 5. Abdominal ultrasound was done routinely for all patients, and repeated if we suspected intraabdominal collection. US guided tubal drainage was done if there was any abdominal collection.
Post hepatectomy liver cell failure (LCF) was defined as an increased international normalized ratio and concomitant hyperbilirubinemia on or after the fifth postoperative day [10] . We adopted the definition proposed by the International Study Group for Liver Surgery for biliary leakage as "bilirubin concentration in the drainage fluid at least 3 times the serum bilirubin concentration on or after postoperative day 3 or when there was a need for radiologic or operative management of biliary collections or bile peritonitis" [11] . Posthepatectomy hemorrhage was defined as a drop in hemoglobin level of more than 3 g/dl from the post-operative baseline level and/or any post-operative transfusion of packed red blood cells for a falling hemoglobin and/or the need for radiological or surgical intervention to control bleeding [12] .
Immunohistochemistry
Paraffin-embedded sections from the tumors were deparaffinized with xylene, followed by decreasing concentrations of ethanol. Then, the sections were treated with 3% hydrogen peroxide in methanol for 10 min to block endogenous peroxidase activity. Slides were heated in vapor power using EDTA at pH 9.4 for antigen retrieval. Sections then were incubated for 1 h at 37 C with primary antibodies (CK7, CK19, EMA and Hep-par) from DAKO, CA, USA. The sections were then incubated in an EnVision system (DAKO, CA, USA) for 30 min at 37 C with washing in phosphate buffered saline. Diaminobenzidine was used as the chromogen.
Follow up
Follow up was carried out at 1 month, 3 months and then every 6 months. Each visit included a clinical examination, routine laboratory investigation (including complete blood picture, liver function, blood sugar and tumor markers CEA, CA19-9), and abdominal ultrasound and abdominal computed tomography (CT) to search for recurrence after resection.
Data collection
Preoperative clinical data, intra-operative data, postoperative course, postoperative complications, recurrence rate and survival rate were collected.
Assessments
The primary outcome measure was Post hepatectomy liver cell failure (LCF). Secondary outcomes analyzed included duration of operation, amount of blood loss, blood transfusion, length of postoperative stay, postoperative morbidity including (biliary leakage, internal hemorrhage, liver cell failure, development of ascitis, esophageal bleeding, PV thrombosis), hospital mortality rate, recurrence rate and survival rate.
Statistical analysis of the data in this study was performed using SPSS software, version 17 (Chicago, IL). Descriptive data were expressed as means with standard deviation or medians with ranges. Categorical variables were described using frequency distributions. Independent sample t-test was used to detect differences in the means of continuous variables and Chi-square test was used in cases with low expected frequencies. Survival curves were done using the KaplaneMeier method, and differences in survival curves were compared by a cox-regressional analysis. P values < 0.05 were considered significant.
Results
243 patients underwent surgical resection for pathologically proven hilar cholangiocarcinoma. The tumor cells were positive for CK7, CK19, and EMA, but negative for Hep-par, which supported the diagnosis of cholangiocarcinoma (Fig 1) . Liver cirrhosis was present in 102 patients (41.9%) while 141 patients (57.1%) had non-cirrhotic liver. There was no significant difference between the cirrhotic and non-cirrhotic groups regarding patient age, sex and preoperative biliary drainage (Table 1) .
The clinical presentation and preoperative liver function are presented in table [1] .
Intraoperative data are shown in Table 2 . Surgical resection in the cirrhotic group included left hepatectomy in 36 patients (35.3%), right hepatectomy in 16 patients (15.7%) and local resection of segment 4 in 50 patients (49%). In the non-cirrhotic group, left hepatectomy was done in 78 patients (55.3%), right hepatectomy in 39 patients (27.7%) and local resection of segment 4 in 24 patients (17%). The incidence of major hepatectomy was significantly higher in the non-cirrhotic group (P ¼ 0.001). Also, caudate lobe resection was more frequently performed in the non-cirrhotic group (P ¼ <0.001).
The postoperative data are shown in Table 3 Cirrhosis was associated with significantly lower overall and disease free survival (P ¼ <0.001) ( Table 3 , Fig. 2(a,b) ).
Discussion
The adverse effect of liver cirrhosis on morbidity and mortality following gastrointestinal surgery was reported in many studies
[13e17]. In the past, cirrhosis has been considered a contraindication to major gastrointestinal surgery and the hospital mortality rates have been found to be 20% to 38% for cirrhotic patients undergoing major abdominal operations [13e18]. Cirrhotic patients are at an increased tendency of bleeding, sepsis, hepatic decompensation including hepatic coma [14e16]. Now, major surgical operations can safely be performed in cirrhotic patients with improvement in preoperative care, surgical techniques with minimal intraoperative bleeding and improvement in medical management [13e16] .
No guideline has been issued for the management of resectable hilar cholangiocarcinoma in cirrhotic patients. In the presence of cirrhosis, the management of hilar CC requires careful patient selection, good perioperative care, adequate counseling on operative risk and good decision on extent of resection. Although complete surgical resection remains the only hope for cure for patients with hilar CC, it represents a major challenge to hepatobiliary surgeons [19] . The tumor extent in the biliary system, radial growth of the tumor and portal vein infiltration are the main determinants of the extent of resection during surgery for hilar CC [20] . In cirrhosis, the surgeon is concerned with the volume and quality of the remnant liver after resection to avoid posthepatectomy LCF [21] .
Surprisingly, preoperative liver functions were more affected in the non-cirrhotic patients. Serum ALP and liver enzymes were higher in the non-cirrhotic group but with significant difference in SGPT only. This can be explained by early detection of extrahepatic CC in patients with cirrhosis during routine follow-up for cirrhosis [2] . There was no significant difference between the two groups regarding serum albumin and prothrombin time despite there was impaired synthetic function of the liver in cirrhosis. This justified the exclusion of cirrhotic patients who were unfit for surgical resection from the study population [2] .
The role of preoperative biliary drainage in jaundiced patients remains controversial. The presence of cholangitis mandate biliary drainage, but there is no proof that routine biliary drainage in all patients facilitates resection or reduces postoperative complication. In most cases biliary drainage of a hemiliver is sufficient since drainage of 30% of the liver is enough to relieve jaundice. In contrary, biliary stents are associated with greater postoperative infection [22e24] . In this study, 48 (47.06%) patients in the cirrhotic group and 61 (43.3%) patients in the non-cirrhotic group required unilateral biliary drainage.
Cirrhosis is expected to be associated with increased blood loss and need for blood transfusion. In this study, there was no significant difference between the cirrhotic and no-cirrhotic groups regarding blood loss and the need for transfusion. This can be explained by the surgeon's preference to carry out local resection in cirrhosis. Vitamin K injection and fresh frozen plasma were given to reduce bleeding tendency. Suture ligature was preferred rather than cautery when possible.
The main concern to achieve successful surgical management of hilar CC is to reduce the postoperative morbidity [25] . The most devastating complication after surgery is post-hepatectomy LCF. Although we adopted a more conservative approach regarding surgical resection in cirrhotic patients, the incidence of postoperative LCF was significantly higher in cirrhotic patients (P ¼ <0.001). That inevitably resulted in longer hospital stay in the cirrhotic group. However, this did not reach statistical significance. R0 resection is one of the most important prognostic factors in hilar CC [19, 26] . Curative R0 resection is achieved in 60e85% of patients with hilar CC according to recent reports [27, 28] . In this series, the overall rate of R0 resection in the two groups was 50%. A positive resection margin was present in 63.7% of cirrhotic patients when compared to 40.4% in non-cirrhotic patients (P ¼ <0.001). This is can be attributed to either more aggressive tumors in cirrhotic patients or to the surgeons' decision to avoid major resection in cirrhotic livers.
According to previous reports, lymph node metastasis is present in 20e50% of hilar CC [27, 28] . Nodal metastasis is an independent prognostic factor in hilar CC [8] . The overall rate of nodal involvement in our experience with the two groups is 38%. Nodal involvement was significantly higher in cirrhotic patients (52%) when compared with non-cirrhotic patients (29.1%) (P ¼ <0.001). Metastatic disease to regional lymph nodes is not uncommon in patients with hilar cholangiocarcinoma. There was a significant difference in survival based on nodal status [29] . Lymph node metastasis beyond the hepatoduodenal ligament (celiac, mesentric LN, or PALN) has a poor prognosis with a 5-year survival of 0e12% [8, 29] . Thus, it is considered a contraindication to resection [8, 29, 30] .
In the current study, caudate lobe resection was carried out in a low proportion of patients (26.5% in cirrhotic and 53.2% in noncirrhotic patients). In the initial period of the study, caudate lobe resection was performed only when infiltrated but now it is resected routinely in all cases of hilar cholangiocarcinoma [31] . Surgeons tend to avoid caudate lobe resection in cirrhotic liver for fear of postoperative liver cell failure and bleeding.
Hilar CC has a dismal prognosis even after R0 resection with an estimated 5 year survival of about 20% [32, 33] . Prognostic factors that are established to affect survival are negative resection margin, caudate lobe resection, lymph node metastasis and well differentiated tumor grade [31, 34, 35] . Liver cirrhosis was found to affect recurrence and survival in hilar CC patients [18] . In this study, Hilar CC in cirrhosis tended to have worse oncological features and more aggressive pattern in the form of R1 resection, lymph node metastasis and poor tumor differentiation. This is similar to the previous studies on intrahepatic CC in liver cirrhosis [2, 36] . The mechanism underlying this finding is still unclear. Tumor aggressive pattern, avoidance of caudate lobe resection together with poor hepatic reserve in cirrhosis can explain the worse 5-years survival in cirrhotic patients (4%) in comparison to non-cirrhotic patients (34.1%) (P ¼ <0.001).
One of the limitations of this study is the retrospective nature. As mentioned before, we used a prospectively maintained database for patients undergoing resection for CC and it had all the preoperative, intraoperative and postoperative data for every patients (routine prospective practice). Another limitation of this study is that the sample size was not calculated as this study was limited by the duration of the study.
Conclusion: Patients with concomitant HCV induced liver cirrhosis and hilar CC should not be precluded from surgical resection. Surgical resection should be limited to patients with well compensated chronic liver diseases. A thorough and precise preoperative evaluation is needed to assess tumor resectability before subjecting patients to surgical exploration. An increased operative risk should be considered during patient counseling. The extent of surgical resection is dependent on the balance between radicality and adequate hepatic reserve in cirrhotic patients. Surgical resection should be limited to experienced surgeons in high volume centers where there is expertise in the management of liver cirrhosis and postoperative complications.
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